Medicofarma Biotech Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0	0.01	0.01	0.51	0.08	0.06
Cash & Short-Term Investments	0	0.01	0.01	0.51	0.08	0.06
Cash Growth	-69.07%	19.23%	-98.97%	556.50%	20.91%	-68.00%
Accounts Receivable	0.49	0.63	0.38	0.58	1.44	0.15
Inventory	-	0	0	0.14	0.56	0.14
Other Current Assets	3.61	3.17	2.13	1.03	0.01	0.04
Total Current Assets	4.1	3.81	2.52	2.26	2.08	0.39
Net Property, Plant & Equipment	8.66	10.56	12.09	12.57	12.7	0
Other Intangible Assets	0.03	0.1	0.15	1.54	1.98	0
Other Long-Term Assets	1.04	0.24	0.21	0	0	0
Total Assets	13.84	14.71	14.97	16.37	16.77	0.4
Accounts Payable	0.03	0.02	0.01	0.83	1.17	0
Other Current Liabilities	-	1.28	2.12	1.05	0.4	0
Total Current Liabilities	3.81	3.15	1.84	2.23	1.69	0.62
Long-Term Debt	3.91	2.53	1.39	0	0	0
Other Long-Term Liabilities	1	0.88	0.44	0.48	0.48	0
Total Long-Term Liabilities	4.91	3.41	1.83	0.48	0.48	0
Total Liabilities	8.73	7.84	5.8	3.76	2.56	0.62
Common Stock	6.8	6.8	6.8	6.8	6.8	0.68
Treasury Stock	-	0	0	0	0	-0.01
Additional Paid-in Capital	17.89	17.89	17.89	17.89	17.89	0.83
Retained Earnings	-10.64	-8.87	-6.57	-3.13	-1.54	-1.33
Shareholders' Equity	5.11	6.87	9.18	12.61	14.2	-0.23
Total Liabilities & Equity	13.84	14.71	14.97	16.37	16.77	0.4
Total Debt	3.91	2.53	1.39	0	0	0
Net Cash (Debt)	-3.91	-2.52	-1.39	0.51	0.08	0.06
Net Cash Growth	-	-	-	556.50%	20.91%	-
Net Cash Per Share	-0.06	-0.04	-0.02	0.01	0.00	0.01
Book Value	5.11	6.87	9.18	12.61	14.2	-0.23
Book Value Per Share	0.08	0.10	0.13	0.19	0.21	-0.03
Tangible Book Value	5.08	6.78	9.02	11.08	12.22	-0.23
Tangible Book Value Per Share	0.07	0.10	0.13	0.16	0.18	-0.03